Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

Summary

The objectives of this study were to evaluate the efficacy, safety, and tolerability of pramipexole, as single-agent therapy or in combination with levodopa, in patients with Parkinson disease living in Hong Kong and Taiwan.

Timeline

Start

1998-11

Primary completion

2000-01

Completion

—

Drugs

Indications